不同剂量去甲氧柔红霉素联合阿糖胞苷诱导治疗年轻初发急性髓系白血病的疗效和安全性分析

OBJECTIVE: To compare the efficacy, safety and long-term prognosis between different dose idarubicin (IDA) combined with cytarabine (IA) as induction chemotherapy in newly diagnosed young patients of acute myeloid leukemia (AML). METHODS: A total of 149 newly diagnosed young AML patients (APL exclud...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Zhonghua Xue Ye Xue Za Zhi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Editorial office of Chinese Journal of Hematology 2016
Gaiak:
论著
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348532/
https://ncbi.nlm.nih.gov/pubmed/27587250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak